Status:
COMPLETED
Role of Interferon-λ and Vaccine Response
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Vaccine Response Impaired
Allogeneic Stem Cell Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
The following observational study will investigate whether the vaccine response (antibodies, T and B cells) after allogeneic stem cell transplantation is influenced by genetic polymorphisms in the int...
Detailed Description
The research project deals with one of the most important virological preventive measures after stem cell transplantation: vaccination against influenza viruses. Patients with allogeneic stem cell tra...
Eligibility Criteria
Inclusion
- held allogeneic stem cell transplantation over 1 year ago
Exclusion
- Known vaccine intolerance (e.g. Protein allergy or severe vaccine-associated side effects, e.g. Guillian Barré syndrome)
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03467074
Start Date
September 1 2014
End Date
December 31 2017
Last Update
October 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Microbiology
Basel, Switzerland, 4031